Literature DB >> 1959638

Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli.

M Kobayashi1, Y Ohi, T Asano, T Hayakawa, K Kato, A Kakinuma, M Hatanaka.   

Abstract

Human T-cell leukemia virus type I (HTLV-I) protease has been purified to homogeneity from a strain of recombinant Escherichia coli. The protease was expressed as a larger precursor, which was autoprocessed to form a mature protease. Protein chemical analyses revealed the coding sequence of mature protease, which agreed with the putative sequence predicted from the sequence of bovine leukemia virus protease. The purified protease processed the natural substrate gag precursor (p53) to form gag p19 and gag p24. The protease activity was inhibited by pepstatin A. These results provide direct evidence that this protease belongs to the aspartic protease family and has an activity consistent with the protease in HTLV-I virion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959638     DOI: 10.1016/0014-5793(91)81162-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT.

Authors:  Gisela Heidecker; Shawn Hill; Patricia A Lloyd; David Derse
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Efficient expression and rapid purification of human T-cell leukemia virus type 1 protease.

Authors:  Y S Ding; S M Owen; R B Lal; R A Ikeda
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 3.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

4.  Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity.

Authors:  A Saiga; T Tanaka; S Orita; A Sato; S Sato; T Hachisu; K Abe; Y Kimura; Y Kondo; T Fujiwara
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity.

Authors:  B Trentin; N Rebeyrotte; R Z Mamoun
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

6.  The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases.

Authors:  Enrique Alvarez; Luis Menéndez-Arias; Luis Carrasco
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease.

Authors:  Chiyuki Awahara; Daiki Oku; Saki Furuta; Kazuya Kobayashi; Kenta Teruya; Kenichi Akaji; Yasunao Hattori
Journal:  Molecules       Date:  2022-03-02       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.